The KLK3 SNP rs17632542, which is in a strong LD with rs62113212, had been previously identified in GWAS as being associated with several PCa-related outcomes, such as the patient’s PSA level, PCa risk, and age at PCa diagnosis and the tumor’s volume, aggressiveness, and Gleason score22. This evidence concerns the gene KLK3 and posterior cortical atrophy.